Martin A. Lehr - Oct 19, 2021 Form 3 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Chief Executive Officer, Director
Signature
/s/ Tyler J. Vivian, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
3
Date filed
10/19/2021, 06:11 PM
Next filing
Oct 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTX Common Stock 89.6K Oct 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTX Series A Preferred Stock Oct 19, 2021 Common Stock 211K Martin Lehr 2000 Trust F1, F2, F3
holding CNTX Series Seed Preferred Stock Oct 19, 2021 Common Stock 586K Martin Lehr 2000 Trust F1, F2, F3
holding CNTX Warrant (right to buy) Oct 19, 2021 Common Stock 52.7K $7.14 Martin Lehr 2000 Trust
holding CNTX Stock Option (right to buy) Oct 19, 2021 Common Stock 281K $4.94 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable upon the date of grant.
F2 N/A
F3 Converts to common stock on a one for one basis.
F4 The stock option vests each month (1/36 each month) from the date of the grant, April 30, 2021.